Recommendations and Evidence for COVID-19 Vaccine in Patients with Systemic Lupus Erythematosus

YANG Qianwen; ZHU Yuyan; HE Xia; PENG Kun; WU Yue; LIU Xinxia; DU Shan; CHEN Min; LIU Yilong; ZHENG Xi; BIAN Yuan; CUI Xiaojiao; SHU Yongquan; TONG Rongsheng

doi:10.14009/j.issn.1672-2124.2022.04.027

您当前的位置：

首页 >

文章列表页 >

Recommendations and Evidence for COVID-19 Vaccine in Patients with Systemic Lupus Erythematosus

更新时间：2022-10-08

- Recommendations and Evidence for COVID-19 Vaccine in Patients with Systemic Lupus Erythematosus
- Vol. 22, Issue 4, Pages: 504-507(2022)
- 作者机构：
  
  1. 电子科技大学医学院
  2. 电子科技大学附属医院·四川省人民医院药学部
  3. 电子科技大学医学院/个体化药物治疗四川省重点实验室
  4. 电子科技大学附属医院·四川省人民医院肾内科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2022.04.027
  CLC： R593.241;R186
- Published：2022，
扫描看全文
YANG Qianwen, ZHU Yuyan, HE Xia, et al. Recommendations and Evidence for COVID-19 Vaccine in Patients with Systemic Lupus Erythematosus. [J]. 22(4):504-507(2022)
DOI：

YANG Qianwen, ZHU Yuyan, HE Xia, et al. Recommendations and Evidence for COVID-19 Vaccine in Patients with Systemic Lupus Erythematosus. [J]. 22(4):504-507(2022) DOI： 10.14009/j.issn.1672-2124.2022.04.027.

摘要

在新型冠状病毒肺炎(COVID-19)疫情持续的当下，自身免疫性疾病导致的免疫异常和应用免疫抑制剂治疗导致的免疫功能低下，使得系统性红斑狼疮(SLE)患者对新型冠状病毒(SARS-CoV-2)的易感性更高。同时，感染是SLE患者死亡的重要危险因素，也可导致SLE患者病情活跃、恶化进而使预后更差。但是，目前SLE患者接种新型冠状病毒疫苗的临床数据尚不充分，使得该类患者的新型冠状病毒疫苗接种存在一定争议。本文从我国目前广泛接种的3类疫苗和SLE的基本情况出发，结合COVID-19与SLE患者相关病例及SLE患者接种新型冠状病毒疫苗的基本情况，通过梳理国际上新型冠状病毒疫苗接种建议，提出SLE患者的新型冠状病毒疫苗接种建议，仅供医学专业医务工作者参考。

Abstract

In the ongoing COVID-19 pandemic

systemic lupus erythematosus

due to immune abnormalities caused by autoimmune diseases and low immune function due to immunosuppressant therapy

patients with systemic lupus erythematosus（SLE） have a higher susceptibility to SARS-COV-2. Meanwhile

infection is an important risk factor for death in patients with SLE

and can also lead to active and worsening of patients with SLE

and resulting in a worse prognosis. However

there are insufficient clinical data on COVID-19 vaccine in patients with SLE

so that COVID-19 vaccine in patients have certain controversies. Based on three types of vaccines widely inoculated in China and the basic situation of SLE

this paper proposes recommendations of COVID-19 vaccine for SLE patients by combing the international recommendations on COVID-19 vaccine for reference of medical professionals.

关键词

新型冠状病毒新型冠状病毒疫苗系统性红斑狼疮疫苗接种

Keywords

SARS-CoV-2COVID-19 vaccineSystemic lupus erythematosusVaccination

references

查看原文

Views

145

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Recommendations and Evidence for COVID-19 Vaccine in Patients with Atopic Dermatitis

Progress of Neutralizing Antibodies Against SARS-CoV-2

Investigation on Medication Status in Patients with Systemic Lupus Erythematosus in 109 Medical Institutions from 9 Cities in China from 2016 to 2020

Visualization Analysis of Research Status and Hotspots of Treatment for COVID-19 Based on CiteSpace

Construction of Drug Treatment Management Scheme for Children with Systemic Lupus Erythematosus

Related Author

BIAN Yuan

YI Xiaoqing

WANG Yueyuan

LI Wenyuan

SHEN Jincui

LI Suping

XIE Chunbao

WU Jingxian

Related Institution

Dept.of Pharmacy, Sichuan Academy of Medical Sciences ＆ Sichuan Provincial People’s Hospital

School of Medicine/Sichuan Provincial Key Laboratory of Individualized Drug Therapy, University of Electronic Science and Technology of China

Dept.of Clinical Laboratory, Sichuan Academy of Medical Sciences ＆ Sichuan Provincial People’s Hospital

Dept.of Neurology, Sichuan Academy of Medical Sciences ＆ Sichuan Provincial People’s Hospital

Dept.of Dermatology, Chengdu Second People’s Hospital

⁰